BRASTER S.A., the owner of a revolutionary technology of LCD matrices production, aiming at developing and selling an innovative device for breast cancer diagnosis, will participate and present its activity at the upcoming 3rd Global Life Sciences Conference in Warsaw.
The conference, which is dedicated to the life science sector, will take place on June 11 in the Trading Room of the Warsaw Stock Exchange. President of the Management Board of BRASTER S.A. Marcin Halicki will participate in the presentation and discussion on i.a. a revolutionary technology of using liquid crystals in supporting breast cancer diagnostics, on-going clinical trials and plans of commercialisation of the Braster device. The event will start at about 3:40 p.m. The presentation to be displayed at the conference will be available earlier on the Company’s website www.braster.eu. The entire conference will also be streamed live on line.
The 3rd Global Life Sciences Conference in Warsaw is the largest international conference devoted to investments in the life science sector. The conference will be attended by over 100 representatives of CEE region’s leading institutions, funds managers and analysts.
Along with BRASTER, several innovative companies from North America and Europe will also present their activities at the conference. This group includes: Milestone Medical, Wand Dental, Perma-Fix Medical, Orgenesis, Oncolytics Biotech, iCo Therapeutics, Advanced Ocular Sciences, MSI Bioscience, Selvita, Cormay, Voxel, Adiuvo, Airway Medix.
The main organiser of the 3rd Global Life Sciences Conference in Warsaw is Dom Maklerski WDM, the leading investment banking institution in the SME segment in the region of Central and Eastern Europe. One of the partners of the conference is the Warsaw Stock Exchange.